Loading...

Prenetics Global Limited

PRE•NASDAQ
Healthcare
Medical - Diagnostics & Research
$18.33
$0.83(4.74%)
U.S. Market opens in 23h 5m

Prenetics Global Limited (PRE) Stock Overview

Explore Prenetics Global Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap257.6M
P/E Ratio-5.00
EPS (TTM)$-3.79
ROE-0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$22.20
3 Months$25.42
1 Year Target$21.23

PRE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Prenetics Global Limited (PRE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $21.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.00 and a market capitalization of 257.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.74%
5-Day Change
1.89%
1-Month Change
-17.25%
3-Month Change
-0.49%
6-Month Change
9.37%
Year-to-Date (YTD) Change
16.38%
1-Year Change
261.54%
3-Year Change
48.42%
5-Year Change
-83.91%
All-Time (Max) Change
-83.91%

Contact Information

https://www.prenetics.com
852 2210 9588
Unit 701-706, K11 Atelier King’s Road, Quarry Bay, NaN, NaN

Company Facts

285 Employees
IPO DateJul 16, 2021
CountryHK
Actively Trading

Frequently Asked Questions